Davidoff F, Carr S
Proc Natl Acad Sci U S A. 1972 Jul;69(7):1957-61. doi: 10.1073/pnas.69.7.1957.
Pyruvate kinase (EC 2.7.1.40) is inhibited by phenethylbiguanide. The kinetics of inhibition are competitive between biguanide and divalent, but not monovalent, metal cation activators of the enzyme; biguanide inhibition thus resembles inhibition by Ca(++). Alteration of either the polar or nonpolar portion of the phenethylbiguanide molecule quantitatively reduces its effectiveness as an inhibitor of pyruvate kinase, but the kinetics of inhibition remain qualitatively unchanged. Measurements of [(3)H]phenethylbiguanide binding to the enzyme indicate the presence of a single class of about 12 binding sites per enzyme molecule; binding characteristics are not significantly different in the presence of either monovalent or divalent metal cations. Studies with (45)Ca(++) and (54)Mn(++) demonstrate about 4 metal binding sites per enzyme molecule; phenethylbiguanide displaces these metal cations from the enzyme. Studies with several enzymes, dependent upon divalent metal cations, of both metal-bridge and substrate-bridge classes fail to show significant inhibition except at much higher phenethylbiguanide concentrations.
丙酮酸激酶(EC 2.7.1.40)受苯乙双胍抑制。抑制动力学在双胍与该酶的二价而非一价金属阳离子激活剂之间具有竞争性;因此双胍抑制类似于Ca(++)的抑制作用。苯乙双胍分子的极性或非极性部分的改变会定量降低其作为丙酮酸激酶抑制剂的有效性,但抑制动力学在定性上保持不变。对[(3)H]苯乙双胍与该酶结合的测量表明,每个酶分子存在一类约12个结合位点;在一价或二价金属阳离子存在下,结合特性没有显著差异。用(45)Ca(++)和(54)Mn(++)进行的研究表明,每个酶分子约有4个金属结合位点;苯乙双胍将这些金属阳离子从酶上置换下来。对几种依赖二价金属阳离子的金属桥和底物桥类型的酶进行的研究表明,除了在高得多的苯乙双胍浓度下,未显示出明显抑制作用。